These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24763863)

  • 1. Expression of fibroblast growth factor 23, vitamin D receptor, and sclerostin in bone tissue from hypercalciuric stone formers.
    Menon VB; Moysés RM; Gomes SA; de Carvalho AB; Jorgetti V; Heilberg IP
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1263-70. PubMed ID: 24763863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RANKL is a mediator of bone resorption in idiopathic hypercalciuria.
    Gomes SA; dos Reis LM; Noronha IL; Jorgetti V; Heilberg IP
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1446-52. PubMed ID: 18480302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated vitamin D receptor levels in genetic hypercalciuric stone-forming rats are associated with downregulation of Snail.
    Bai S; Wang H; Shen J; Zhou R; Bushinsky DA; Favus MJ
    J Bone Miner Res; 2010 Apr; 25(4):830-40. PubMed ID: 19929616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria.
    Favus MJ; Karnauskas AJ; Parks JH; Coe FL
    J Clin Endocrinol Metab; 2004 Oct; 89(10):4937-43. PubMed ID: 15472188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone disease and idiopathic hypercalciuria.
    Zerwekh JE
    Semin Nephrol; 2008 Mar; 28(2):133-42. PubMed ID: 18359394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of an oral sodium phosphate load on parathyroid hormone and fibroblast growth factor 23 secretion in normo- and hypercalciuric stone-forming patients.
    Irzyniec T; Boryń M; Kasztalska J; Nowak-Kapusta Z; Maciejewska-Paszek I; Grochowska-Niedworok E
    Clin Nutr; 2020 Dec; 39(12):3804-3812. PubMed ID: 32386861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of vitamin D receptor, CYP27B1 and CYP24A1 hydroxylases and 1,25-dihydroxyvitamin D
    Melo TL; Esper PLG; Zambrano LI; Ormanji MS; Rodrigues FG; Heilberg IP
    Urolithiasis; 2020 Feb; 48(1):19-26. PubMed ID: 31696245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alterations in bone mineral metabolism in patients with calcium kidney stone disease and polymorphism of vitamin D receptor. Preliminary results].
    Moyano MJ; Gómez de Tejada MJ; García Lozano R; Moruno R; Ortega R; Martí V; Sánchez Palencia R; Miranda MJ; Palma A; Pérez Cano R
    Nefrologia; 2007; 27(6):694-703. PubMed ID: 18336098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased intestinal vitamin D receptor in genetic hypercalciuric rats. A cause of intestinal calcium hyperabsorption.
    Li XQ; Tembe V; Horwitz GM; Bushinsky DA; Favus MJ
    J Clin Invest; 1993 Feb; 91(2):661-7. PubMed ID: 8381825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone resorption in dogs with calcium oxalate urolithiasis and idiopathic hypercalciuria.
    Luskin AC; Lulich JP; Gresch SC; Furrow E
    Res Vet Sci; 2019 Apr; 123():129-134. PubMed ID: 30641472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum sclerostin is associated with recurrent kidney stone formation independent of hypercalciuria.
    Rodríguez D; Gurevich E; Mohammadi Jouabadi S; Pastor Arroyo EM; Ritter A; Estoppey Younes S; Wagner CA; Imenez Silva PH; Seeger H; Mohebbi N
    Clin Kidney J; 2024 Jan; 17(1):sfad256. PubMed ID: 38186870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers.
    Bataille P; Achard JM; Fournier A; Boudailliez B; Westeel PF; el Esper N; Bergot C; Jans I; Lalau JD; Petit J
    Kidney Int; 1991 Jun; 39(6):1193-205. PubMed ID: 1895673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum sclerostin increases in healthy adult men during bed rest.
    Spatz JM; Fields EE; Yu EW; Divieti Pajevic P; Bouxsein ML; Sibonga JD; Zwart SR; Smith SM
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1736-40. PubMed ID: 22767636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal Calcium Absorption among Hypercalciuric Patients with or without Calcium Kidney Stones.
    Vezzoli G; Macrina L; Rubinacci A; Spotti D; Arcidiacono T
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1450-1455. PubMed ID: 27284011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,25(OH)₂D₃ induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming rats.
    Ng AH; Frick KK; Krieger NS; Asplin JR; Cohen-McFarlane M; Culbertson CD; Kyker-Snowman K; Grynpas MD; Bushinsky DA
    Calcif Tissue Int; 2014 May; 94(5):531-43. PubMed ID: 24481706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?
    Sapir-Koren R; Livshits G
    Osteoporos Int; 2014 Dec; 25(12):2685-700. PubMed ID: 25030653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium ions promote primary renal epithelial cell differentiation into cells with bone-associated phenotypes via transforming growth factor-β1-induced epithelial-mesenchymal transition in idiopathic hypercalciuria patients.
    He D; Wang S; Jia Z; Cui L; Lu Y; Hu H; Qin B
    Mol Med Rep; 2015 Mar; 11(3):2199-206. PubMed ID: 25394514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity.
    Grethen E; Hill KM; Jones R; Cacucci BM; Gupta CE; Acton A; Considine RV; Peacock M
    J Clin Endocrinol Metab; 2012 May; 97(5):1655-62. PubMed ID: 22362819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet.
    Frick KK; Asplin JR; Culbertson CD; Granja I; Krieger NS; Bushinsky DA
    Am J Physiol Renal Physiol; 2014 May; 306(9):F1081-7. PubMed ID: 24573387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relation between bone and stone formation.
    Krieger NS; Bushinsky DA
    Calcif Tissue Int; 2013 Oct; 93(4):374-81. PubMed ID: 23247537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.